Schedule 13D ownership disclosure
Onconova Therapeutics Inc
Security class unavailable · CUSIP: 68232V306
Event date: 2019-09-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 100,000
- Percent of class
- 1.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-20-000187
- Form type
- SC 13D
- Filer
- 683 Capital Management, LLC
- CIK
- CIK 1404574
- Filed
- Feb 19, 2020
- Reporting period
- Sep 25, 2019
- Description
- Schedule 13D beneficial ownership